4//SEC Filing
Kelly Paul Edward 4
Accession 0001213900-22-081477
CIK 0001553643other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 5:32 PM ET
Size
5.4 KB
Accession
0001213900-22-081477
Insider Transaction Report
Form 4
Kelly Paul Edward
DirectorChief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2022-12-16+57,042→ 57,042 totalExercise: $3.37From: 2023-03-16Exp: 2032-12-16→ Common Stock (57,042 underlying)
Footnotes (1)
- [F1]The option vests in 16 equal quarterly installments commencing on March 16, 2023.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001658544
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 5:32 PM ET
- Size
- 5.4 KB